ALLISON WISE: Open Payments
NPI 1336556935 · DUNBAR, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,693 in 97 payments from 15 companies in 2025. Trend: 2023 $1,656 · 2024 $1,707 · 2025 $1,693
Food & beverage: $1,693
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 30 | $576 |
| ABBVIE INC. | 20 | $286 |
| AstraZeneca Pharmaceuticals LP | 9 | $206 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $156 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $89 |
| ABIOMED | 2 | $60 |
| GlaxoSmithKline, LLC. | 4 | $59 |
| Lundbeck LLC | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Exact Sciences Corporation | 3 | $41 |
Products named: Ozempic, Rybelsus, CAPLYTA, QULIPTA, AIRSUPRA, REXULTI, XIFAXAN, Wegovy.
Industry payments across WV — which companies pay providers there.
